Ginger.io, a behavioral health analytics startup, has raised a $6.5 million Series A funding round led by Khosla Ventures. Existing seed investors True Ventures and Romulus Capital also participated.
Drawing on research from the MIT Media Lab, Ginger.io’s mobile application uses an individual’s smartphone to identify changes in behavior that correlate with his or her health. The company is evaluating its system across a number of key conditions including depression, diabetes and cardiovascular disease. The latest version of the Ginger.io platform, released earlier this fall, provides both a provider team and a patient with health insights based on that person’s behavior.
Since raising its seed round just over a year ago, the company has expanded, absorbed the Rock Health startup Pipette, and opened a San Francisco, California office in addition to its Cambridge, Massachusetts location.
Ginger.io is actively hiring for engineering and business development roles, in both Boston and San Francisco, says the company. It is also recruiting individuals living with Diabetes, Congestive Heart Failure (CHF) and Crohn’s & Ulcerative Colitis to help accelerate the development and deployment of the Ginger.io system by becoming early adopters.
[Image courtesy: Ginger.io]